Norges Bank
VIR icon

Norges Bank’s Vir Biotechnology VIR Stock Holding History

Norges Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,900
Closed -$257K – 1965
2024
Q2 		$257K Sell
28,900
-95,400
-77% -$915K ﹤0.01% 1910
2024
Q1 		$1.26M Buy
124,300
+92,387
+289% +$941K ﹤0.01% 1777
2023
Q4 		$321K Sell
31,913
-1,057,624
-97% -$9.66M ﹤0.01% 1916
2023
Q3 		$10.2M Buy
1,089,537
+312,387
+40% +$4.46M ﹤0.01% 1467
2023
Q2 		$19.1M Buy
777,150
+140,200
+22% +$3.52M ﹤0.01% 1276
2023
Q1 		$14.8M Sell
636,950
-91,610
-13% -$2.34M ﹤0.01% 1414
2022
Q4 		$18.4M Buy
728,560
+112,693
+18% +$2.76M ﹤0.01% 1309
2022
Q3 		$11.9M Buy
615,867
+17,503
+3% +$445K ﹤0.01% 1464
2022
Q2 		$15.2M Buy
598,364
+45,247
+8% +$1.06M ﹤0.01% 1374
2022
Q1 		$14.2M Buy
553,117
+55,697
+11% +$1.65M ﹤0.01% 1561
2021
Q4 		$20.8M Buy
497,420
+103,751
+26% +$4.06M ﹤0.01% 1454
2021
Q3 		$17.1M Buy
393,669
+101,994
+35% +$4.42M ﹤0.01% 1573
2021
Q2 		$13.8M Sell
291,675
-213,852
-42% -$9.72M ﹤0.01% 1684
2021
Q1 		$25.9M Sell
505,527
-65,717
-12% -$3.54M 0.01% 1377
2020
Q4 		$15.3M Sell
571,244
-68,094
-11% -$2.21M ﹤0.01% 1647
2020
Q3 		$21.9M Sell
639,338
-173,578
-21% -$7.47M 0.01% 1363
2020
Q2 		$33.3M Buy
+812,916
New +$27.3M 0.01% 1122
2020
Q1 		– Sell
-25,000
Closed -$314K – 2074
2019
Q4 		$314K Buy
+25,000
New +$335K ﹤0.01% 2067

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank's VIR Position: Q3 2024 in Review

Norges Bank sold out of Vir Biotechnology (VIR) in Q3 2024, closing a stake of 28,900 shares — an estimated $257K sold.

Norges Bank first reported a position in VIR in Q4 2019 and held it in 18 quarters. The position peaked at $33.3M in Q2 2020. 197 funds tracked by Wall St. Rank hold VIR as of Q3 2024.

  • Norges Bank reported no remaining Vir Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Norges Bank sold 28,900 Vir Biotechnology shares in Q3 2024, an estimated $257K.
  • Norges Bank first reported a position in Vir Biotechnology in Q4 2019 and held it in 18 quarters.
  • Norges Bank's Vir Biotechnology position peaked at $33.3M in Q2 2020.
  • 197 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.